Alnylam Pharmaceuticals I...

267.06
11.30 (4.42%)
At close: Apr 02, 2025, 3:59 PM
262.00
-1.89%
After-hours: Apr 02, 2025, 05:21 PM EDT

Givlaari Revenue

History

Quarter Value Change Growth
Sep 30, 2024 71.04M 8.92M +14.35%
Jun 30, 2024 62.13M 4.07M +7.01%
Mar 31, 2024 58.06M -107.05M -64.84%
Dec 31, 2023 165.1M 110.95M +204.91%
Sep 30, 2023 54.15M -251.56M -82.29%
Jun 30, 2023 305.7M 29.38M +10.63%
Mar 31, 2023 276.33M 14.65M +5.60%
Dec 31, 2022 261.68M 29.41M +12.66%
Sep 30, 2022 232.27M 18.75M +8.78%
Jun 30, 2022 213.51M 26.64M +14.26%
Mar 31, 2022 186.87M -11.64M -5.86%
Dec 31, 2021 198.51M 31.47M +18.84%
Sep 30, 2021 167.04M 6.23M +3.88%
Jun 30, 2021 160.81M 25.04M +18.44%
Mar 31, 2021 135.77M 22.93M +20.32%
Dec 31, 2020 112.84M 13.64M +13.75%
Sep 30, 2020 99.21M 88.21M +802.04%
Jun 30, 2020 11M 5.72M +108.53%
Mar 31, 2020 5.27M -40.79M -88.55%
Sep 30, 2019 46.07M 7.83M +20.49%
Jun 30, 2019 38.23M 11.94M +45.41%
Mar 31, 2019 26.29M 14.22M +117.73%
Dec 31, 2018 12.07M 11.62M +2525.00%
Sep 30, 2018 460K n/a n/a